Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Octreotide since 2013?

What pharmacies pay, not what you pay. Octreotide has 3 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Octreotide 1,000 MCG/5 ML Vial: $9.28 per unit at the 2014 survey and $5.34 at 2026 (−42%, thin).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Octreotide3 products in NADAC
2products with a price history
  1. Octreotide has 3 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 1 product costs pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. 1 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
  4. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Octreotide 1,000 MCG/5 ML Vial

Generic

$9.28 per mL at the 2014 year-end survey (1 NDC) and $5.34 at the 2026 survey (4 NDCs): −42%, a thin comparison.

$0$14.072014: median $9.28 per mL, 1 NDC priced2016: median $14.07 per mL, 1 NDC priced2020: median $9.20 per mL, 2 NDCs priced2024: median $6.54 per mL, 5 NDCs priced2025: median $5.15 per mL, 4 NDCs priced2026: median $5.34 per mL, 4 NDCs priced201420162020202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per mLLowest to highestNDCs priced
2014 (2014-12-31)$9.281
2016 (2016-12-28)$14.071
2020 (2020-12-30)$9.202
2024 (2024-12-25)$6.545
2025 (2025-12-31)$5.154
2026 (2026-11-11)$5.344

Octreotide 1,000 MCG/ML Vial

Generic

$52.18 per mL at the 2013 year-end survey (7 NDCs) and $41.76 at the 2016 survey (3 NDCs): −20%.

$0$52.182013: median $52.18 per mL, 7 NDCs priced2016: median $41.76 per mL, 3 NDCs priced20132016
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per mLLowest to highestNDCs priced
2013 (2013-12-25)$52.187
2016 (2016-12-28)$41.763

Octreotide 5,000 MCG/5 ML Vial

Generic

Priced once, at the 2016 year-end survey: $41.76 per mL across 1 NDC.

Year-end surveyMedian per mLLowest to highestNDCs priced
2016 (2016-12-28)$41.761

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

How many companies make Octreotide?

The FDA Orange Book lists 9 generic makers as marketed in its largest dosage form for Octreotide, and the first generic approval is dated 28 March 2005. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Octreotide on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).